PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

被引:66
作者
Elias, D [1 ]
Akuffo, H
Britton, S
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[2] Armauer Hansen Res Inst, Addis Ababa, Ethiopia
[3] Swedish Inst Infect Dis Control, Stockholm, Sweden
[4] Karolinska Inst, Dept Med, Infect Dis Unit, S-17176 Stockholm, Sweden
关键词
tuberculosis; BCG vaccination; interferon gamma; immunity;
D O I
10.1016/j.trstmh.2004.08.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Correlates of protection against tuberculosis are crucial for the evaluation of new vaccine candidates and for the demonstration of their potential efficacy. Such correlates can be proposed on the basis of animal models. In this study, we hypothesized that protection against tuberculosis (TB) induced by bacillus Calmette-Guerin (BCG) correlates with in vitro TB antigen-specific IFN-gamma production. BCG vaccination, known to provide effective protection against TB in animals, was used to investigate the use of in vitro IFN-gamma production as a marker of BCG-induced protection against TB. Our results show that BCG vaccination does provide substantial protection against challenge with Mycobacterium tuberculosis. However, despite previous compelling evidence that Th1 type immune responses are essential for TB immunity, the magnitude of in vitro purified protein derivative (PPD)-specific IFN-gamma production assessed during the course of TB infection did not correlate with protection. This emphasizes the need to identify further correlates of protection, in addition to IFN-gamma, to be used as markers of protective immunity against M. tuberculosis and/or to identify M. tuberculosis antigens inducing IFN-gamma that correlate with protective immunity. (c) 2004 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. ALL rights reserved.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 24 条
  • [1] [Anonymous], 1994, WHO/TB/94
  • [2] EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE
    COLDITZ, GA
    BREWER, TF
    BERKEY, CS
    WILSON, ME
    BURDICK, E
    FINEBERG, HV
    MOSTELLER, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09): : 698 - 702
  • [3] DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE
    COOPER, AM
    DALTON, DK
    STEWART, TA
    GRIFFIN, JP
    RUSSELL, DG
    ORME, IM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2243 - 2247
  • [4] Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002
  • [5] DOUVAS GS, 1985, INFECT IMMUN, V50, P1
  • [6] ELIAS D, VACCINE
  • [7] Correlates of protective immunity to Mycobacterium tuberculosis in humans
    Ellner, JJ
    Hirsch, CS
    Whalen, CC
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 : S279 - S282
  • [8] FINE PEM, 1989, REV INFECT DIS, V11, pS353
  • [9] AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION
    FLYNN, JL
    CHAN, J
    TRIEBOLD, KJ
    DALTON, DK
    STEWART, TA
    BLOOM, BR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2249 - 2254
  • [10] Immunology of tuberculosis
    Flynn, JL
    Chan, J
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 93 - 129